Milwaukee pharmaceutical company Estrigenix Therapeutics gets SBIR grant

Milwaukee-based Estrigenix Therapeutics, Inc., a pharmaceutical company focused on research in estrogen biology, is the recipient of a $300,000 National Institute of Health (NIH) Small Business Innovation Research (SBIR) grant. The funding will be used to support pre-clinical studies for one of Estrigenix’s lead compounds, which can help ease the symptoms of women suffering from

Want to Read the Entire Article?

Become a BizTimes Insider to get immediate access to our subscriber-only content and much more.

Become an Insider Now

Already an Insider? Log In

Ashley covers startups, technology and manufacturing for BizTimes. She was previously the managing editor of the News Graphic and Washington County Daily News. In past reporting roles, covering education at The Waukesha Freeman, she received several WNA awards. She is a UWM graduate. In her free time, Ashley enjoys watching independent films, tackling a new recipe in the kitchen and reading a good book.

No posts to display